Bilateral differences in lower-limb strength in people with multiple sclerosis (MS) have been clinically observed. The objectives of this study were to quantify bilateral differences in lower-limb performance and metabolism during exercise. Eight ambulatory individuals with mild MS with an Expanded Disability Status Scale score of 2.6 +/-1.6 and seven non-MS controls completed bilateral assessments of muscle strength and incremental cycling. Individuals with MS had significant (p < 0.05) between-leg differences in leg strength (strong leg: 43.3 +/-12.7 kg vs weak leg: 37.7 +/-15.2 kg), peak oxygen uptake (strong leg: 13.7 +/-3.2 mL/kg/ min vs weak leg: 10.6 +/-3.0 mL/kg/min), and peak workload (strong leg: 73.4 +/-22.3 W vs weak leg: 56.3 +/-26.2 W). No between-leg differences were found in controls (p > 0.05). As anticipated, individuals with MS exhibited significantly greater asymmetry for strength, oxygen uptake, and workload than controls (p < 0.05). The differences between legs varied from 2% to 30% for maximal strength and 4% to 66% for cycling workload in the MS group and 4% to 24% and 0% to 8% for the control group, respectively. Preliminary evidence suggests that the magnitude of differences may be related to limitations in aerobic function.
INTRODUCTION
Multiple sclerosis (MS) is a chronic and progressive autoimmune disease of the central nervous system [1] . Symptoms vary widely across individuals; however, fatigue is a common complaint [2] [3] [4] [5] , with 40 percent of those surveyed identifying it as their most disabling symptom [2, 4] . Fatigue has been defined as, "a subjective lack of physical or mental energy that is perceived by the individual or caregiver to interfere with activities of daily living" [5] . This type of fatigue is often referred to as symptomatic fatigue to distinguish it from muscular fatigue.
Muscular fatigue in individuals with MS is often described as being related to central and/or peripheral impairments. Central impairment presents itself as declines in efferent motor outflow (neural drive) to the muscle resulting in activation failure, reduced muscle recruitment [6] , and/or delayed neural transmission [7] , while peripheral impairment reflects reduced forcegenerating mechanisms [8] within the skeletal muscle as a result of altered metabolic characteristics [9] [10] [11] . The relationship between symptomatic and muscular fatigue is complicated because of their interrelated influences.
Clinical examinations of individuals with MS have often observed differences in strength and function between legs [12] . The differences in leg strength have also been reported in the scientific literature [13] . In a 2005 case study, White and Dressendorfer reported bilateral differences in leg performance in an individual with exertional monoparesis [14] . Additionally, leg power asymmetry, unilateral leg weakness, and differences in bone density have been observed in people with MS [13, [15] [16] [17] . Despite these observations, less is known about aerobic metabolism and endurance performance during dynamic lower-limb activity.
Therefore, the first purpose of this study was to formally quantify whether ambulatory individuals with mild MS would display bilateral differences in lower-limb performance and metabolism during exercise. We hypothesized that ambulatory individuals with mild MS would exhibit between-leg differences in strength, peak oxygen uptake (VO 2 ), and maximal cycling workload during incremental exercise and that these differences would be greater than those seen in nondisabled controls. Second, we explored the relationship between bilateral differences and a functional performance test, the 6-minute walk test (6MWT).
METHODS

Participants
Fifteen volunteers, eight with MS (6 female and 2 male) and seven nondisabled controls (5 female and 2 male) participated in the study. We included individuals with MS if they had a physician diagnosis of relapsingremitting MS [18] , had an Expanded Disability Status Scale (EDSS) score of <6.5 (ambulatory without aid), and had not experienced an exacerbation for a minimum of 6 mo prior to enrollment. We excluded participants with multiple risk factors for cardiovascular disease (according to American College of Sports Medicine guidelines) or orthopedic limitations, regardless of MS status [19] . Each participant had physician's clearance and signed a consent form approved by the University of Georgia Institutional Review Board prior to participation.
Study Design
Each participant underwent assessments of leg extensor strength and limb-specific VO 2 . Prior to formal assessments, participants were familiarized with and practiced all testing procedures. To maximize consistency, we tested participants at approximately the same time of day and asked them to abstain from exercise, alcohol, caffeine, and smoking for 12 h prior to the visit. We separated testing sessions by a minimum of 48 h to ensure adequate recovery. Additionally, since the legs were tested on different days, we used questionnaires related to fatigue (Modified Fatigue Impact Scale [MFIS] physical domain) and the Profile of Moods State-Brief Version (POMS-B) for daily screening purposes. If a participant's score on either the MFIS physical domain or the POMS-B were 2.5 standard deviations (SDs) higher than their previous scores, we retested them at a later date once fatigue levels returned to normal levels. We measured self-reported physical activity using a questionnaire developed in-house that asked about frequency, duration, and intensity of physical activity during a typical week. We measured whole-body and limb-specific lean and fat mass by dual-energy X-ray absorptiometry (Lunar iDXA, GE Healthcare; Chalfont St. Giles, Bucks, United Kingdom) to verify that legs were similar between and within groups.
Muscle Strength
We assessed quadriceps strength of each leg by maximal voluntary isometric contractions (MVICs) using a custom chair that set the knee angle at a constant 70°. We stabilized the participant's thigh and torso during testing. We connected the lever arm of the chair to a force transducer, and the digitized signal was sent directly to a computer and recorded using MATLAB (MathWorks; Natick, Massachusetts). Following a brief warm-up consisting of three submaximal contractions and a 5 min rest period, the participant performed three MVICs using the highest value to determine the strong leg (less affected) and the weak leg (more affected).
Unilateral Incremental Cycling
We assessed limb-specific peak VO 2 (one-legged cycling) using a continuous ramp protocol. Prior to testing, the participant completed a standardized 2 to 3 min warm-up of cycling at 25 W, followed by a 5 min rest period. After the warm-up, single-leg cycling started at 0 W and increased 1 W every 2 s until he or she met one of our defined test termination criteria: (1) any symptomimpairing ability to continue or indication of risk to participant's safety or health, (2) volitional exhaustion, or (3) pedaling rate below 40 rpm (rotations per minute).
We used these criteria for all subsequent tests. We measured expired gases continuously using a calibrated metabolic cart (TrueMax 2400, ParvoMedics; Sandy, Utah) and averaged them over 30 s intervals. We recorded heart rate (HR) by telemetry (RS800, Polar Electro; Kempele, Finland) and obtained overall ratings of perceived exertion (RPEs) using a Borg 10-point scale at the end of each minute [20] . We measured blood lactate by finger stick performed at rest before and 3 min after the exercise test (Lactate Pro; Carlton, New South Wales, Australia). The interclass correlation for repeated measures for peak VO 2 was 0.96 (confidence interval [CI]: 0.84-0.99) and for peak workload was 0.96 (CI: 0.89-0.99).
Single-Leg Cycling Leg Position
During all single-leg cycling tests, we securely fastened the participant's foot to the pedal and positioned the nonexercising leg to ensure no contribution to workload. We positioned the exercising leg so that it was almost fully extended when the crankarm was at the lowest position.
Functional Performance Test: 6-Minute Walk Test
We used the 6MWT as a measure of exercise tolerance and overall functional limitation [21] . We conducted this test according to McGavin et al. [22] . It has previously been used in studies with individuals with MS.
Statistical Analysis
We performed all analyses using SPSS version 16 (IBM Corporation; Armonk, New York). We used independent t-tests to detect across-group differences and dependent t-tests to compare across-limb differences. We used a correlation to assess the relationship among leg differences and performance during the 6MWT. Data are expressed as mean ± SD. An alpha of 0.05 was our criteria to establish statistically significant differences. We reported precise p-values, and when appropriate, Cohen's d. Based on White and Dressendorfer [14] , we determined that changes 25 percent could be detected in leg differences using strength, peak workload, and peak VO 2 , corresponding to an effect size of ~0.8 and power of approximately 80 percent. Using this information, we calculated our sample size to be approximately 7 to 10 participants per group.
RESULTS
Participant Characteristics
Eight ambulatory (no assistance devices) individuals with relapsing-remitting MS, in remission, and seven nondisabled controls completed the study. The EDSS score of 2.6 ± 1.6 indicated a mild to moderate impairment in the participants with MS. Duration of the disease was 12.6 ± 8.1 yr (ranging from 6-31 yr). Age, height, weight, body mass index, percent body fat, and self-report of physical activity were not statistically different between groups ( Table 1) . Leg lean and fat mass were not statistically different between legs or groups (p > 0.05).
Leg Strength
MVIC was statistically different between legs in the group with MS (strong leg: 43.3 ± 12.7 kg, weak leg: 37.7 ± 15.2 kg, p = 0.004, effect size: Cohen d = 1.20 [which is considered large [23] ]), whereas the control group did not exhibit statistical differences between legs (strong leg: 39.8 ± 12.1 kg, weak leg: 37.9 ± 15.2 kg, p = 0.40). The average difference in isometric strength was 18.2 ± 9.4 percent (range: 2%-30%) in the group with MS and 11.3 ± 7.9 percent (range: 4%-24%) in the control group. As expected, the difference between legs was significantly greater in the group with MS than in controls (MS: 8.34 ± 5.7 kg, control: 2.1 ± 6.1 kg, p < 0.01, effect size: Cohen d = 1.1 [which is considered large [23] ]) (Figure 1 ). Cohen d = 1.8 mL/kg/min, workload: Cohen d = 1.2 W) with no statistical differences observed between legs for respiratory exchange rate, peak lactate, peak HR, ventilation, and RPE. We observed no statistical differences between legs in the control group for all the measured variables. The average difference between legs for maximal work was 28.0 ± 21.3 percent (range: 4%-66%) and 4.3 ± 2.8 percent (range: 0%-8%) for the individuals with MS and controls, respectively. As anticipated, bilateral leg differences were significantly greater in the group with MS for peak VO 2 and peak workload than in controls (MS: 3.1 ± 1.9 mL/kg/ min, control: 0.83 ± 2.0 mL/kg/min, p < 0.05, Cohen d = (Figures 2-3) .
Unilateral Incremental Exercise
Six-Minute Walk Test
The individuals with MS covered significantly less distance during the 6MWT than controls (MS: 474.3 ± 93.1 m, control: 626.9 ± 94.0 m, p < 0.05). We also observed a between-group significant correlation between the 6MWT and leg differences in peak workload (r = 0.65, p < 0.05).
DISCUSSION
The major findings of this study indicate that ambulatory individuals with relapsing-remitting MS and relatively low disability exhibited statistically significant bilateral differences in leg strength, oxidative capacity (peak VO 2 ), and work performed and that these differences were significantly greater than controls. Additionally, people with MS displayed a larger range of bilateral differences than controls, especially when measured during cycling rather than maximal isometric strength. Preliminary evidence suggests that the magnitude of bilateral differences might limit functional abilities. These findings suggest that, despite being ambulatory and having low disability, our sample of people with MS not only exhibited significant performance differences between limbs but that these differences were significantly greater than the differences observed in our control group.
People with MS often experience decrements in motor drive, which often affects the lower limbs disproportionally [12] *p < 0.05 represents statistically significant differences in group means. HR = heart rate, MS = multiple sclerosis, RER = respiratory exchange ratio, RPE = rating of perceived exertion, VE = ventilation, VO 2 = oxygen uptake. related to muscle physiology, function, and fatigue in people with MS appear to be interpreted based on data apparently collected from a single leg or single muscle group. For example, some reports are based on data from the left leg [24] , while others are from the right leg [25] or the specified leg was unclear [10, [26] [27] . Some investigators have reported study findings based on tests using the weaker (more affected) side of the body [8, 28] . To date, limited published information is available that describes interlimb differences in individuals with MS [14] .
Activities of daily living such as walking require sufficient synchronization of bilateral motor unit recruitment and discharge rates. Typically, the legs are recruited bilaterally and limb preference may switch depending on the complexity and conditions during the movement [29] . Individuals with MS can be limited in their ability to activate motor units during bilateral movements, which may result in the development of compensatory strategies in recruitment patterns to their stronger (less affected) limb [30] . Therefore, the stronger (less affected) side might actually become stronger as a result of compensatory actions of the stronger leg in our group of individuals with MS. When looking at leg preference (dominant vs nondominant), four individuals in the MS group preferred a side (dominant) that was significantly weaker than their nondominant side. This was specific to our group with MS because the controls not only exhibited no significant bilateral differences but their stronger leg was their preferred (dominant) leg.
Bilateral differences in oxidative capacity and maximal aerobic capacity between legs are usually negligible [31] [32] . For example, previous studies have shown no differences between legs in peak VO 2 during single-leg cycling protocols at constant and incremental loads in both athletic and nonathletic groups [31] [32] . These studies also report no differences in the magnitude of muscle activation (recruitment patterns) as measured by electromyography (EMG) [31] [32] . Data from these studies suggest that each leg performs work and functions aerobically at approximately the same level [31] . In participants with MS, we found that the strong leg performed at relatively higher capacity than the weaker leg. Although we collected no EMG data in the present study, our observations may indicate dissimilar neural activation pattern in the weak leg in those with MS, indicated by the leg's premature task failure as evidence by the reduced performance during incremental cycling.
Our data might suggest that the weak leg limits aerobic exercise tolerance and performance. We did observe a correlation between the 6MWT and between-leg differences in peak workload (r = 0.77, p < 0.05), suggesting that ~59 percent of limitations in functional capacity might be explained by leg differences during dynamic actions. However, these data are preliminary at best and would need to be verified in a much larger study because of our small sample size. Additional research is needed to identify central and peripheral factors that might contribute to bilateral differences observed in our sample. Research is needed to identify whether bilateral differences can be reduced following training and physical therapy tailored to an individual who exhibits significant differences in strength and function between limbs (legs and arms). Despite the small sample size, our findings highlight the need for an emphasis on bilateral assessment and the need for therapies targeted at reducing such differences.
CONCLUSIONS
The major finding of this study was that the statistically significant bilateral differences in lower-limb strength and aerobic performance in a group of ambulatory individuals with MS were not observed in our sample of individuals without MS. The differences between legs in individuals with MS were greater when measured as work performance rather than maximal isometric strength. These data highlight the need for research studies and therapeutic interventions to account for differences in limb function. The observation of limb differences may be more apparent for functional activities rather than simpler measures of muscle strength. Finally, these leg differences should be considered when designing future research study protocols. Our findings highlight new information relevant to exercise therapy in people with MS; however, we appreciate that there are limitations to our study such as the small sample size and lack of ability to distinguish the influence of central and peripheral factors on bilateral differences. Additional research is needed to specifically assess muscle quality and function in individuals, such as those with MS, susceptible to developing bilateral differences.
